Espín-Paredes E, Guevara-López U, Arias-Rosa JC, Pérez-Carranco ML

Language: Spanish
References: 25
Page: 69-73
PDF size: 173.22 Kb.

ABSTRACT

The DM is a public health ‘s problem associated to a damage of multiple organs and secondary pain of polineuropathy. Objective: Identify the risks factors associated to the develop of NDD. Method: Retrospective, Descriptive and Comparative study of 87 patients divided in two groups: 1) patients with NDD and 2) Patients with NDND. Results: The prevalence of NDD was greater than NDND; significative statistic difference was found between the groups in comparison whith the blood glucose levels, glycosilated hemoglobin levels and time of course of DM. NDD was more prevalent in the female gender. Likewise NDD had a earlier onset in relation to previous reports and it was associated to the next comorbidities: hypertension, dyslipidemias and sleep disorders.

REFERENCES

1. Bredley SG, Giannas A, et al. Painful diabetic polyneuropathy: epidemiology, pain description and quality of life. Diabetes Research and Clinical Practice 2000;47:123-128.

2. Betancourt JA, Covarrubias GA, Guevara LU. Mecanismos generadores y consideraciones terapéuticas futuras de la polineuropatía diabética dolorosa. Rev Mex Anest 2008;31:28-36.

3. Miser WF. The management of type 2 diabetes mellitus FOCUS on Quality. Prim Care Clin Office Prac 2007;34:1-38.

4. American Diabetes Association. Standards of medical care in diabetes 2008. Diabetes Care 2008;31:s12-s24.

5. Huizinga MM, Peltier A, et al. Painful diabetic neuropathy: A management centered review. Clinical Diabetes 2007;25:2-10.

6. Tunks ER, Crook J, et al. Epidemiology of chronic pain with psychological comorbidity: Prevalence, risk, course and prognosis. Can J Psychiatric 2008;53:24-34.

7. Gore M, Brendenburg NA, et al. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006;22:681-685.

8. Gonzalez-Clemente JM, Palma S, et al. Is diabetic mellitus coronary heart disease equivalent? Results of a meta-analysis of prospective studies. Rev Esp Cardiol 2007;60:1167-1670.

9. Steter C, Alleman S, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. American Heart Journal .2006;152:27-38.

10. Crawford1 F, Inkster M, et al. Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis. Q J Med 2007;100:65-86.

11. American Diabets Association. Standards of Medical Care in Diabetes-2008. Diabetes Care 2008;31:12-24.

12. Selvin E, Marinopoulos S, et al. Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004:141:421-431.

13. Huizinga MM, Amanda Peltier A. Painful diabetic neuropathy: A management-centered review. Clinical Diabetes 2007;25:6-15.

14. Boulton AJM. Diabetic neuropathy: classification, measurement and treatment. Current Opinion in Endocrinology & Diabetes 2007;14:141-145.

15. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73-78.

16. Stettler C, Allemann S, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 2006;152:27-38.

17. Mayer-Davis EJ. Type 2 diabetes in Youth: Epidemiology and current research toward prevention and treatment. J Am Diet Assoc 2008;108:S45-S51

18. Sorensen L, Siddal PJ, et al. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care 2008;31:980- 981.

19. Polityshka LJ, et al. Quality of life its relationship to the degree of illness acceptance in patients with diabetes and peripheral diabetic neuropathy. Advances in Medical Sciences 2007;52:144-147.

20. Maser RE, Braxton DM, et al. The Association Between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 2003;26:1895-1901.

21. Duby JJ, Campbell RK, et al. Diabetic neuropathy: An intensive review. Am J Health Syst Pharm 2004;61:114-122.

22. Roy-Byrne PP, Davidson WD, et al. Anxiety disorders and comorbid medical illness. General Hospital Psychiatry 30 2008:208-225.

23. Miser WF. The management of type 2 diabetes mellitus FOCUS on quality. Prim Care Clin Office Pract 2007:1-38.

24. Va´rkonyi1 T, Kempler P. Diabetic neuropathy: new strategies for treatment. Diabetes Obesity and Metabolism 2008;10:99-108 .

25. Sadosky A, McDermott AM, Brandenburg NA. A Review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Practice 2008;8:45–56.